Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide compounding begins with licensed 503A pharmacies that obtain pharmaceutical-grade semaglutide powder or solution from verified pharmaceutical suppliers and then prepare personalized injections for individual patients. Unlike mass-manufactured medications, compounded semaglutide is mixed to exact specifications in facilities regulated by state pharmacy boards and the FDA. PlexusDx works exclusively with these licensed compounding pharmacies to ensure quality, safety, and affordability across all 50 states.
How Licensed 503A Compounding Pharmacies Obtain Semaglutide
Licensed 503A compounding pharmacies source semaglutide from pharmaceutical wholesalers and API (active pharmaceutical ingredient) suppliers that meet strict quality standards. These suppliers must be registered with the FDA and comply with Current Good Manufacturing Practice (CGMP) regulations, ensuring the raw material is pharmaceutical-grade and sterile-ready. Pharmacists then verify the source, test incoming materials, and document the chain of custody before any compounding begins.
The sourcing process is fundamentally different from how brand-name Ozempic is manufactured. While Novo Nordisk produces Ozempic in large-scale facilities using proprietary methods, compounding pharmacies receive pre-manufactured semaglutide and prepare smaller batches tailored to patient-specific doses and delivery formats. This model allows PlexusDx to offer semaglutide injections at a lower cost—starting at $149 per month—without compromising pharmaceutical integrity.
The 503A Licensing and Regulatory Framework
A 503A compounding pharmacy is a state-licensed facility that prepares customized medications under federal and state oversight, distinct from 503B outsourcing facilities that manufacture larger quantities for broader distribution. The FDA recognizes 503A pharmacies as part of traditional pharmacy practice, and they must meet USP (United States Pharmacopeia) standards for sterile and non-sterile compounding. Each state pharmacy board conducts inspections, and pharmacists must hold current licenses and specialized certifications in compounding.
PlexusDx exclusively partners with 503A-licensed compounding pharmacies—never 503B facilities—to maintain transparency and compliance with the regulatory framework that governs personalized medication preparation. This commitment ensures that every semaglutide injection is prepared under pharmacist supervision, documented in patient records, and subject to the same quality checks as pharmacy-dispensed medications. Patients can verify their pharmacy's 503A status through state pharmacy board databases.
Quality Control and Sterility Standards for Compounded Semaglutide
Once a 503A pharmacy receives pharmaceutical-grade semaglutide, compounding technicians prepare injections in certified cleanroom environments using aseptic technique to eliminate bacterial and fungal contamination. Each batch is assigned a lot number, expiration date, and documentation trail that includes the ingredient source, preparation date, and pharmacist verification. Facilities must maintain temperature controls, use sterile equipment, and follow written standard operating procedures (SOPs) that exceed basic pharmacy standards.
Compounding pharmacies also conduct stability testing and potency assurance to confirm that semaglutide remains effective throughout its designated shelf life, typically 30–90 days when stored at recommended temperatures. PlexusDx patients receive their compounded semaglutide with detailed storage instructions and expiration dates specific to their shipment. This level of individualized quality control differs from retail pharmacies, which dispense pre-packaged medications manufactured months or years in advance.
Why PlexusDx Uses Licensed Compounding Pharmacies for Personalized Weight Loss
Compounding pharmacies enable PlexusDx to offer semaglutide at a flat rate of $149 per month because they eliminate the markup associated with brand-name pharmaceutical distribution and insurance intermediaries. Patients pay no membership fees, require no insurance, and can use HSA or FSA funds to cover costs—making personalized GLP-1 therapy accessible to those who might otherwise face prohibitive out-of-pocket expenses. The compounding model also allows for rapid dose adjustments and format flexibility (injectable or oral) without waiting for new prescriptions to be filled through retail channels.
PlexusDx pairs compounded semaglutide with optional precision genetic testing through the Precision Peptide Genetic Test ($99 after the first month), which analyzes 14 metabolic pathways and 150+ genetic insights to identify how individual variants in genes like GLP1R and GIPR influence medication response. This data-driven approach ensures that patients receive not only affordable medication but also guidance tailored to their genetic predisposition to GLP-1 efficacy, maximizing results while keeping monthly costs flat regardless of dose level.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide from PlexusDx as safe as brand-name Ozempic?
Yes. PlexusDx semaglutide comes from licensed 503A compounding pharmacies that source pharmaceutical-grade material and prepare injections under FDA oversight and USP sterility standards. The active ingredient is identical to brand-name semaglutide; the difference is preparation method and cost. All compounding is performed by licensed pharmacists in certified cleanroom environments.
What happens if my dose needs to increase?
Your dose may need to go up—but your price won't. PlexusDx charges a flat $149 per month for compounded semaglutide injection across all dose levels, eliminating the flat per-compound pricing that makes brand-name weight loss medications unaffordable. Your compounding pharmacy adjusts your preparation without raising your monthly cost.
Do I need insurance to use PlexusDx compounded semaglutide?
No. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations. HSA and FSA accounts are eligible for payment, and patients typically save significantly compared to insurance copays for brand-name GLP-1 medications. Pricing starts at $149 per month flat.
Can my PlexusDx semaglutide be stored the same way as Ozempic?
Compounded semaglutide has a shorter shelf life than refrigerated Ozempic pens and should be stored according to the specific instructions provided with your shipment, typically 30–90 days when kept at the recommended temperature. Your pharmacy will include detailed storage and expiration information with your medication. Always follow the guidance on your label rather than assuming it matches brand-name storage.
How does the Precision Peptide Genetic Test help with compounded semaglutide?
PlexusDx's Precision Peptide Genetic Test ($99 after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide and other GLP-1 medications. This insight helps your provider optimize your treatment plan and predict which dose level may work best for you, ensuring your compounded medication aligns with your genetic metabolism.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Medications: Can You Take Spironolactone and Semaglutide Together?
Is Compounded Semaglutide Being Taken Off the Market?